Pelago Bioscience AB

We are happy to announce we have signed a strategic agreement with Cancer Research Horizons: “Cancer Research Horizons passionately recognise the importance of building and investing in tools and technologies regarded as critical for enabling deeper mechanistic understanding of our targets and their interactions with ligands. Quantitative assessment of cellular target engagement through Pelago Bioscience’s Cellular Thermal Shift Assay (CETSA®) is one such technology: this will form a key part of our drug discovery toolbox, helping to build a robust data package for our therapeutic discovery programmes and, ultimately, improve translation to patient benefit.” Dr. Rachel Grimley, SVP Drug Discovery, Cancer Research Horizons Read the full press release here: https://hubs.la/Q02F-Z8S0 We are very happy to be able to help Cancer Research Horizons in their quest to beat cancer. #DrugDiscovery

We're proud to be sponsoring ON Helix 2024 at the Babraham Research Campus on 4th July, focused on "New Horizons for Bio Innovation." The conference will feature keynote presentations, panel discussions, and ample networking opportunities. You don't want to miss this chance to connect with industry leaders and explore the latest advancements in life sciences. Pelago Bioscience is honored to kick off the event with an opening keynote presentation by Kia Pedersen titled: “New Horizons for Therapeutic Modalities: advances in emerging fields and associated challenges.” Our Senior Key Account Manager Marianne Alksnis will also be there, and we look forward to engaging with all of you. Register to attend here: ON Helix 2024 #ONHelix24 #Pharma #LifeSciences #PelagoBioscience #Innovation #BioInnovation #Networking

Pelago Bioscience is proud to be a sponsor for the upcoming Millner Symposium in Cambridge, UK, on Tuesday, 2nd July. This event, organized by the Milner Therapeutics Institute, brings together leading scientists from academia and industry to discuss cutting-edge research and its potential applications in the pharma and biotech industries. Marianne Alksnis and Kia Pedersen will be representing Pelago Bioscience at the symposium, so make sure to say hi if you spot them in the crowd. We will also present our poster titled: "Unbiased selectivity profiling with the Cellular Thermal Shift Assay (CETSA) powered by mass spectrometry detection." We encourage all attendees to visit our poster session to learn more about our research and engage with our team. See you there! #PelagoBioscience #MillnerSymposium #Cambridge #Biotech #Pharma #Networking #Research #Innovation #CETSA

Excited to announce Pelago Bioscience AB as a sponsor and attendee of the upcoming #CreativeDisruption Forum: How Tech is Changing Small Molecule Drug Hunting, in Cambridge on June 13th! This event is perfect for leaders in the #LifeSciences industry looking to connect with peers and thought leaders. The Format of the Forum: Morning: Key Opinion Leader Interviews (including Pelago Bioscience CEO, Michael Dabrowski) Afternoon: Interactive workshops (think tanks!) Michael Dabrowski will be interviewed by Tony Sedgwick about how our CETSA® technology can enhance the success rate of finding new active ingredients in drug discovery. Our Head of Sales, Magnus Lejelöv will be there to network, share insights on overcoming common #DrugDiscovery challenges, and build valuable connections. Interested? Reach out to us for more information: https://hubs.la/Q02zXSDb0 #PelagoBioscience #CETSA #Biotech #SmallMolecule #Cambridge

We're excited to announce that we will be presenting our services at Babraham Research Campus next Wednesday, June 12th! Join us at our showcase event happening during Cambridge Wide Open Day. Visit our booth to discuss how we can bring certainty to your Drug Discovery projects. 📆 Date: 12 June 2024 🕙 Time: 10:00 – 15:00 📍 Location: The Cambridge Building Market Restaurant Our team of experts, Marianne Alksnis, Magnus Lejelöv and Stina Lundgren is excited to discuss how we can help with confirming Target Engagement, enhancing Target Validation, and understanding compound Mechanisms of Action. For more information about our services, visit our website: https://hubs.la/Q02zDhGn0 #DrugDiscovery #BabrahamReseachCampus #PelagoBioscience

Are you attending #SLASEurope2024? If yes, make sure to attend this exciting presentation by Fiona Jeganathan, Head of Screening and Pharmacology at Alzheimer's Research UK on screening for Alzheimer's Disease using CETSA® technology! 🗓️ Date & Time: Tuesday, May 28, 2024, 15:30 – 16:00 CEST 📍 Room/Location: 112 In her presentation, Fiona will delve into the use of Cellular Thermal Shift Assay in conjunction with a B cell RAMOS assay to identify small molecule modulators of the PLCg2. This enzyme, predominantly expressed in immune and haematopoietic cells, plays an important role in signal transmission networks associated with Alzheimer's Disease. By leveraging CETSA technology, Fiona and her team have successfully identified novel modulators, paving the way for potential therapeutic strategies targeting Alzheimer's Disease. Don't miss this opportunity to learn about the latest advancements in Alzheimer's research and how CETSA technology is accelerating drug discovery efforts! Additionally, we are excited to share that our team members, Helena Almqvist - Project advisor and, Christina Velasco - Product Manager, will be representing Pelago Bioscience AB at the conference. If you spot them in the crowd, please feel free to say hello. They will be delighted to connect with you and discuss ideas, share experiences, and address any burning questions you may have. See you at SLAS Europe! #DrugDiscovery #AlzheimersResearch #CETSA #SLASEurope24

Pelago Bioscience AB is excited to participate in Discovery Europe 2024! Come and explore our latest innovations and insights. Here's where you can find us: 👥 Booth Exhibition: Stop by our Booth 9 to explore how we can help accelerating your drug discovery projects and meet our expert team - Yasmin Andersson, Stina Lundgren and Magnus Lejelöv. 📊 Poster Presentation: Dive into our latest research findings and interact with our top minds. 🎤 20-Minute Oral Presentation: Don't miss out on a presentation by our Head of Business Development, Stina Lundgren titled "The use of CETSA® in Physiological Relevant Drug Discovery". 📆: May 22 at 11:10 📍: Track 1: Identification & Validation of Novel Targets 🌐 For detailed information about our poster and oral presentation, please visit: https://hubs.la/Q02xKqMt0 See you there! 🚀 #OGDiscovery #Discovery24 #DrugDiscovery

We are thrilled to share that we will be showcasing our high-throughput screening services at Oxford Global Discovery Europe 2024 in Basel! Join us at the Congress Center Basel to explore how our offerings can support your Drug Discovery journey. ✨ If you haven't registered yet, visit our website to secure one of three complimentary Guest Passes. Link here: https://hubs.la/Q02xxYV60 Stay tuned for additional details about our talk and poster presentation. #OGDiscovery #Discovery24 #drugdiscovery

Exciting update! Our Project Advisor, Helena Almqvist has been chosen as the Keynote Speaker at the Medicinal Chemistry Strategy Meeting East Coast USA 2024 on May 15th in Princeton! Mark your calendars: 📅 Date: May 15 🕒 Time: 4:15 PM - 4:45 PM 📍 Location: Hyatt Regency - Princeton 🔥 Title: Drug Discovery at the Melting Point: CETSA® At her presentation, she will discuss how Pelago Bioscience AB and our technology CETSA®, Cellular Thermal Shift Assay, can help you asses target engagement and bring your projects forward with confidence. Don't miss this opportunity to learn how our high-throughput screening services provide: - 🧬 Physiologically relevant, robust data - 🏷️ Completely label-free assay - 🔄 Transferability across matrices This means actionable data, faster timelines, and better decisions sooner. Join us for an enlightening session! Interested in learning more? Explore our services here: https://hubs.la/Q02x4Wcy0 🌐 #MedicinalChemistry #DrugDiscovery #EastCoastUSA #StrategyMeeting

In addition to our team in Oxford, UK, we've also dispatched a team to Seoul this week! Pelago Bioscience AB is delighted to participate in the Swedish Bio-Pharma Delegation at Biokorea 2024. Join us and meet our representatives Stina Lundgren, Head of Business Development, and Daniel Martinez Molina, CSO, at the Nordic Pavilion B11 to discover how CETSA® can support your drug discovery project. https://hubs.la/Q02wj_630 #biokorea #BK2024